Menu
Back to Journals » Psoriasis: Targets and Therapy
ESCI
Impact Factor
ISSN: 2230-326X
- View all (178)
- Volume 15, 2025 (22)
- Volume 14, 2024 (23)
- Volume 13, 2023 (7)
- Volume 12, 2022 (22)
- Volume 11, 2021 (14)
- Volume 10, 2020 (8)
- Volume 9, 2019 (13)
- Volume 8, 2018 (12)
- Volume 7, 2017 (9)
- Volume 6, 2016 (15)
- Volume 5, 2015 (13)
- Volume 4, 2014 (5)
- Volume 3, 2013 (4)
- Volume 2, 2012 (10)
- Volume 1, 2011 (1)
Journal Articles:
Original Research
Metabolic Syndrome in Psoriasis and Psoriatic Arthritis in a Mixed Race Population: Comparison of Their Prevalences
Acioly PMG, Mazzillo MDLT, Machado CJ, Camargo C, Penetra MA, Januário V, Reis BRD, Ramos-e-Silva M, Carneiro S
Psoriasis: Targets and Therapy 2024, 14:123-130
Published Date: 31 October 2024
Review
The Effects of Cardiometabolic Comorbidities on Biologic Treatment for Psoriasis with Respect to PASI Scores: A Qualitative Systematic Review
Osman A, Nigro A, Taylor AC, Saal R, Ormaza Vera A, Enos C
Psoriasis: Targets and Therapy 2024, 14:1-10
Published Date: 10 January 2024
Review
Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies
Heidemeyer K, May Lee M, Cazzaniga S, Yawalkar N, Naldi L
Psoriasis: Targets and Therapy 2023, 13:33-58
Published Date: 22 September 2023
Case report
Therapeutic Management of a Case of Severe Psoriasis Coexistent with Bullous Pemphigoid in the Elderly
Di Lernia V, Peccerillo F, Ficarelli E
Psoriasis: Targets and Therapy 2023, 13:27-31
Published Date: 22 August 2023